Cardiovascular Kidney Metabolic Syndrome Linked to Increased Cancer Risk and Holistic Health Strategies

The medical community is increasingly recognizing that cardiovascular, kidney, and metabolic health are not isolated systems but are deeply intertwined. This intersection, known as cardiovascular-kidney-metabolic (CKM) syndrome, is now being linked to a heightened risk of malignancy, suggesting that the framework for treating cardiometabolic health must expand to include cancer prevention as a core objective, not a secondary concern.

Recent analysis of health data from nearly 1.4 million individuals in Japan indicates a positive correlation between the severity of CKM syndrome and the likelihood of developing cancer. Although the study is observational and cannot prove causation, the findings highlight a critical need for a more comprehensive approach to risk stratification in patients with multi-organ dysfunction – one that spans cardiology, nephrology, endocrinology, and oncology as well as public health planning.

Quantifying Cancer Risk Across CKM Stages

The risk of cancer does not remain static as CKM syndrome progresses; rather, it escalates significantly as a patient moves into more advanced stages. While early stages show a marginal increase in risk, the jump in probability at stages 3 and 4 suggests a tipping point in systemic health where accumulated damage across organ systems begins to translate into markedly higher malignancy risk.

Although the absolute risk varies by age, sex, and baseline health, the relative pattern is clear: cancer risk rises sharply once CKM syndrome moves into later stages. That reinforces the idea that CKM staging can serve as a practical, clinic-ready tool for anticipating oncological risk, not just cardiovascular events.

“These findings suggest that CKM staging may help identify individuals at increased cancer risk, supporting a more holistic approach to risk stratification beyond cardiovascular outcomes,” researchers stated.

The Biological Drivers of Comorbidity

The link between CKM syndrome and cancer is likely rooted in shared pathophysiological mechanisms. Rather than one condition directly causing the other in a simple linear fashion, both are driven by systemic failures that create a fertile environment for multiple chronic diseases to flourish over time.

The interconnected nature of cardiovascular, kidney, and metabolic diseases involves several key drivers:

• Systemic inflammation: A chronic immune response that damages tissues, disrupts normal cell repair, and can promote tumor growth.
• Insulin resistance: Metabolic dysfunction that alters cell growth and signaling, affecting how cells respond to growth factors and potentially encouraging malignancy.
• Oxidative stress: An imbalance of free radicals and antioxidants that leads to cellular and DNA damage, increasing the likelihood of cancer-promoting mutations.
• Dysfunctional adiposity: The excessive accumulation and dysfunction of fatty tissue, which acts as an endocrine organ secreting pro-inflammatory cytokines and hormones that worsen both metabolic and cardiovascular risk.

Tochi Okwuosa, DO, director of cardio-oncology services at Rush University Medical Center, noted that “A common factor between the CKM syndrome and cancer is inflammation, which is likely a link between both disease processes.” She further explained the cascade effect: “We know that obesity increases insulin resistance and diabetes, and both processes increase inflammation, which in turn increases cardiovascular risk factors such as hypertension, which then increases kidney disease. All of these factors eventually lead to heart disease and stroke.” Together, these overlapping biological pathways help explain why cancer risk appears to spike as CKM burden accumulates.

Public Health Implications and Population Vulnerability

The scale of this health challenge is immense. Data suggests that up to 90% of adults in the United States may possess at least some components of CKM syndrome, with the highest prevalence seen among men, older adults, and Black individuals. This disparity underscores the role of social determinants of health, including income, neighborhood environment, and historical inequities in access to preventive care and high-quality treatment.

For health agencies and policymakers, the emerging CKM-cancer link adds weight to existing debates over how aggressively to fund community-based prevention, screening programs, and early-life interventions. It suggests that failure to address obesity, diabetes, hypertension, and kidney disease together – rather than in silos – could have downstream consequences for cancer incidence and national healthcare spending.

The overlapping risk profiles suggest that the same lifestyle and environmental factors that drive CKM progression also fuel cancer risk. These include:

• Chronic tobacco use
• Excessive alcohol consumption
• Poor dietary patterns (specifically high intake of ultra-processed foods)
• Sedentary lifestyles and inadequate sleep
• Advanced age

Michael McConnell, MD, a clinical professor of cardiovascular medicine at Stanford Medicine, emphasized that the association is most potent in advanced stages. “I think the stronger argument is the shared risk factors not that poor CKM health ‘causes’ cancer,” he stated. “This emphasizes prevention is key to both, particularly as the cancer risk mostly associated with CKM stage 3 and 4, not earlier stages 1 and 2.”

Integrating Oncology into Cardiometabolic Care

The identification of CKM syndrome by the American Heart Association (AHA) in 2023 marked a shift toward multidisciplinary care and gave clinicians a common language to describe overlapping cardiovascular, kidney, and metabolic risk. That shift is now intersecting with policy discussions, as CKM offers a framework that can be incorporated into federal prevention strategies and reimbursement models overseen by agencies such as the U.S. Centers for Disease Control and Prevention.

The discovery of a cancer link necessitates further integration, where cardiologists, nephrologists, and endocrinologists coordinate with oncologists to manage high-risk patients and make sure that cancer screening is matched to overall risk rather than siloed guidelines alone.

For patients in advanced stages, the clinical focus must shift toward aggressive management and enhanced surveillance. “CKM is a more holistic approach to cardiometabolic and kidney health, so it’s helpful to know earlier that these contribute to risk of both [cardiovascular disease] and cancer,” McConnell stated. “For those with more advanced CKM stages, it’s important to manage cardio, metabolic, and kidney issues as we now have very effective therapies, and to be aware of the association with cancer risk, so appropriate cancer screenings [are done].”

Christopher Berg, MD, a non-interventional cardiologist at MemorialCare Heart and Vascular Institute, noted that while the research identifies at-risk groups, the primary solution remains systemic health improvement. “The chief health concerns of people with CKM should be to work to reduce their risk of cardiovascular disease, which will in turn reduce their risk of cancer. Broadly, if it is good for the heart, it will help reduce your risk of cancer as well,” Berg stated.

To mitigate these risks at a population level, health systems are encouraged to adopt guidelines such as the Life’s Essential 8 framework from the AHA, which targets the root causes of inflammation and metabolic decay through better diet, regular activity, adequate sleep, and avoidance of tobacco, among other measures. Employers, insurers, and public payers are increasingly aligning wellness and prevention programs with these principles.

“The most important habits are those that reduce inflammation, which appears to be the primary source of the CKM syndrome,” Okwuosa stated. Berg added that the transition to a healthier lifestyle should be incremental to avoid patient burnout. “While this laundry list of goals may seem unwieldy and overwhelming, actionable steps anyone can take immediately would be to focus on increasing physical activity and reducing the amount of ultra-processed food they eat,” Berg stated. “These steps in turn can help address multiple domains associated with CKM syndrome, promote overall health, and decrease the risk of cardiovascular disease and cancer.”